Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Flyte Aviation, Inc.VTAK · Entity 8648 | Director | March 26, 2026 | March 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Flyte Aviation, Inc.
Report date March 26, 2026 · Filed March 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.15 · Expires 2036-03-26 | Direct | 40,000 |
Reported balance
After 2026-03-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-26 · Grant · Acquired 40,000 · Balance 40,000 F1: Options vest 100% on 180 day anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Options vest 100% on 180 day anniversary of grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2026 Filed Mar 30, 2026 17:58 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | GrantOptions (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001437749-26-010376 · rdgdoc.xml · derivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-03-26 F1 · derivative.exercise_date: Options vest 100% on 180 day anniversary of grant date. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:54 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | ConversionSeries X Convertible Preferred Stock · Derivative | 7.932 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037173 · rdgdoc.xml · derivative · entry 2 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:54 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | ConversionCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037173 · rdgdoc.xml · nonDerivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:33 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | GrantOptions (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001654954-25-009660 · section16.xml · derivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-08-12 F1 · derivative.exercise_date: Options vests 1/3 per year beginning on first anniversary of grant date. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 16:37 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001437749-25-002428 · rdgdoc.xml · derivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock · 100,000 shares Expires 2035-01-29 F1 · derivative.exercise_date: 33.33% exercisable on January 29, 2025, 33.33% exercisable on January 29, 2026, and 33.34% exercisable on January 29, 2027. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:30 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | GrantOptions (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001654954-24-000420 · section16.xml · derivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-08 F1 · derivative.exercise_date: Options vests 8 1/3% every three months beginning April 8, 2024. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:20 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | ConversionSeries X Convertible Preferred Stock · Derivative | 1.779 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003615 · section16.xml · derivative · entry 2 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.932 Underlying: Common Stock · 7,932 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American. F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:20 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | ConversionCommon Stock | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003615 · section16.xml · nonDerivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 17:17 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantSeries X Convertible Preferred Stock · Derivative | 9.711 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003028 · doc4.xml · derivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9.711 Underlying: Common Stock · 9,711 shares Expires not disclosed F1 · derivative.exercise_price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. F2 · kind: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000). F1 · price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. F1 · derivative.exercise_date: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.